Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.

Department of Pathology, Medical University of Graz, Graz, Austria.
American Journal of Surgical Pathology (Impact Factor: 4.59). 04/2005; 29(3):347-53.
Source: PubMed

ABSTRACT We investigated 20 spindle cell (sarcomatoid) metaplastic carcinomas (MCs) without squamous differentiation. In addition, five high-grade phyllodes tumors were assessed for comparison. Our immunohistochemical antibody panel included pan-cytokeratin (CK), low molecular weight CK (CK8/18), four basal cell type CKs (34betaE12, CK5/6, CK14, and CK17), vimentin antibodies, as well as antibodies to established (SMA, CD10, p63, S-100, maspin, calponin, GFAP, SM-myosin), and novel (CD29, 14-3-3sigma) myoepithelial markers. Sixteen of the 20 tumors (80%) expressed at least two markers of the combination CD10/p63/SMA. S-100 detected 1 case negative for CD10/p63/SMA and 3 cases that only expressed one marker of this combination. While 18 MCs (90%) were positive for CD29, 14-3-3sigma (11 cases) and maspin (9 cases) were observed in 55% and 45%, respectively. Antibodies to pan-CK and the basal cell type CKs were strongly reactive in 12 tumors (60%), but in 6 cases (30%) positivity for these markers was weak and only focal; 2 MCs showed no positivity for CK. The stromal component of all phyllodes tumors was positive for vimentin, whereas all other investigated markers were absent except for focal p63 and CD10 expression in 1 case each. Our findings convincingly show a myoepithelial immunophenotype in sarcomatoid MCs, which is demonstrated by the presence of basal cell type CKs and the combination of the established myoepithelial markers CD10, p63, SMA, and S-100. We conclude that tumors with weak or even absent CK expression should only be diagnosed as primary sarcomas of the breast after exclusion of a myoepithelial immunophenotype. CD29 and 14-3-3sigma represent valuable novel myoepithelial markers in these diagnostically difficult cases.

Download full-text


Available from: Sebastian Leibl, Aug 14, 2015
  • Source
    • "The histogenesis of spindle cell carcinoma remains controversial. However, recent immunohistochemical and genomic profiling studies indicate that these tumors are part of the spectrum of basal-like carcinomas and display a myoepithelial or epithelial to mesenchymal transition-like molecular make-up [9] [10] [11]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Compared to epithelial lesions, spindle-cell lesions of the breast are relatively uncommon and, because of that, may cause diagnostic difficulty. The majority of these spindle cell lesions, such as fibromatosis, nodular fasciitis, spindle-cell carcinoma, inflammatory myofibroblatic tumor and angiosarcoma, resemble their more common non-mammary counterparts. A few others, such as pseudoangiomatous stromal hyperplasia for example, specifically arise in breast. This review discusses these mammary spindle cell lesions with a focus on their salient histological features.
    The Open Breast Cancer Journal 05/2014; 4(1). DOI:10.2174/1876817201002011095
  • Source
    • "The 14-3-3 r protein has been described as a valuable myoepithelial marker in human mammary tissue (Simpson et al., 2004; Leibl et al., 2005). In our study, double immunostaining of tissues for 14-3-3 r and the MEC specific marker p63, confirmed that 14- 3-3 r is a highly sensitive marker of MECs since all p63 positive cells were also positive for 14-3-3 r. "
    [Show abstract] [Hide abstract]
    ABSTRACT: 14-3-3 σ protein is a negative cell cycle regulator, with both reduced and elevated levels associated with cancer in humans. This study assessed the expression of this protein in canine mammary tissues using immunohistochemistry and Western blotting. 14-3-3 σ was detected in 97% of the mammary tissue samples examined and was found in both myoepithelial (MECs) and epithelial (ECs) cells. Expression levels were elevated and reduced in neoplastic ECs and MECs, respectively (P<0.001). Intense expression of 14-3-3 σ was detected in neoplastic ECs infiltrating blood vessels and lymph nodes and suggests a possible role for this protein in the malignant transformation of mammary neoplasms. Moreover, double immunostaining for 14-3-3 σ and the MEC-specific marker p63, confirmed that 14-3-3 σ is a highly sensitive marker of MECs since all p63-positive cells were also positive for 14-3-3 σ. However, this protein is not exclusive to MECs as ECs also labelled positively.
    The Veterinary Journal 12/2011; 190(3):345-51. DOI:10.1016/j.tvjl.2010.12.015 · 2.17 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mammary tumors are the most common type of tumors affecting female dogs. There is a remarkable heterogeneity among mammary tumors and the underlying cause is poorly understood. The aims of this thesis were, firstly, to investigate whether tumor cells show plasticity and thereby get insight into how heterogeneity arises and, secondly, to identify embryonic developmental genes expressed in the tumors. A comparison between sarcomas and carcinomas in these respects was of central importance for this investigation. Primary tumors, an osteosarcoma, a spindle-cell tumor, and a simple carcinoma were cloned and resulting clones were subcutaneously injected in mice, to form experimental tumors. By following the expression of lineage markers in the primary tumors, the clones in vitro, and in the experimental tumors, it was found that the sarcoma clones showed distinct signs of plasticity, and that the carcinoma clones transformed in line with an epithelial to mesenchymal transition. The expression of genes coding for the developmentally important bone morphogenetic proteins was studied in the clones from the tumors described above. Further, three groups of tumors, i.e., osteosarcomas, fibrosarcomas and simple carcinomas were studied using gene expression profiling technology. Thereby, extensive expression of homeobox genes, a group of important developmental genes, was identified. Sarcomas displayed the most prominent expression of developmental genes, both for the number of genes expressed and the levels of expression for the respective genes. Interestingly, many homeobox genes expressed in the sarcomas have been linked to craniofacial development, a process dependent on neural crest contribution. In line with this, cell markers for neural crest derived tissues were also expressed in the sarcomas, including tooth, nerve and glial markers. The results show that sarcomas are more plastic and have a more diverse gene expression than carcinomas. Heterogeneity seen in sarcomas of the mammary gland may be related to the expression of homeobox genes.
Show more